Utilization of B-type natriuretic peptide and NT-proBNP in the diagnosis of pleural effusions due to heart failure

Current Opinion in Pulmonary Medicine

Volumn 17, Issue 4, 2011, Pages 215-219

  Porcel, José M ^a  

^a HOSPITAL ARNAU DE VILANOVA   (Spain)

Author keywords

B type natriuretic peptide; heart failure; natriuretic peptides; NT proBNP; pleural effusion

Indexed keywords

ADENOSINE DEAMINASE; AMINO TERMINAL PRO ATRIAL NATRIURETIC PEPTIDE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMINO TERMINAL PRO C TYPE NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; DENDROASPIS NATRIURETIC PEPTIDE; EDETIC ACID; LACTATE DEHYDROGENASE; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C; PRO ATRIAL NATRIURETIC PEPTIDE; PRO BRAIN NATRIURETIC PEPTIDE; SIGNAL PEPTIDE; UNCLASSIFIED DRUG; URODILATIN;

AGE; AMINO ACID SEQUENCE; BAYES THEOREM; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DYSPNEA; HALF LIFE TIME; HEART FAILURE; HEART MUSCLE CELL; HUMAN; IMMUNOASSAY; KIDNEY FAILURE; LACTATE DEHYDROGENASE BLOOD LEVEL; META ANALYSIS (TOPIC); OBESITY; PLEURA EFFUSION; PLEURA FLUID; PROBABILITY; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; REVIEW; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; TUBERCULOUS PLEURISY;

BIOLOGICAL MARKERS; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PLEURAL EFFUSION;

EID: 79958799527     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3283455cda     Document Type: Review

References (27)

1. Porcel JM. Pleural effusions from congestive heart failure. Semin Respir Crit Care Med 2010; 31:689-697.
2. Porcel JM. Pearls and myths in pleural fluid analysis. Respirology 2011; 16:44-52.
3. Tung A, Bilaceroglu S, Porcel JM, et al. Biomarkers in pleural diseases. US Respiratory Disease 2011; 7.
4. Porcel JM. The use of probrain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions resulting from heart failure. Curr Opin Pulm Med 2005; 11:329-333. (Pubitemid 41073158)
5. Taub PR, Gabbai-Saldate P, Maisel A. Biomarkers of heart failure. Congest Heart Fail 2010; 16 (Suppl 1):S19-S24.
6. Omland T, Hagve TA. Natriuretic peptides: physiological and analytical considerations. Heart Fail Clin 2009; 5:471-487.
7. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347:161-167. (Pubitemid 34764819)
8. Januzzi JL Jr, Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Am J Cardiol 2005; 95:948-954. (Pubitemid 40487743)
9. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults. Circulation 2009; 119:1977-2016.
10. Mohammed AA, Januzzi JL Jr. Natriuretic peptides in the diagnosis and management of acute heart failure. Heart Fail Clin 2009; 5:489-500.
11. Porcel JM, Vives M, Cao G, et al. Measurement of pro-brain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions due to heart failure. Am J Med 2004; 116:417-420. (Pubitemid 38299487)
12. Porcel JM, Chorda J, Cao G, et al. Comparing serum and pleural fluid probrain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria. Respirology 2007; 12:654-659. (Pubitemid 47414870)
13. Porcel JM, Martínez-Alonso M, Cao G, et al. Biomarkers of heart failure in pleural fluid. Chest 2009; 136:671-677. This series evaluated the pleural fluid concentrations of three biomarkers for heart failure (BNP, NT-proBNP, and ST2) in 181 patients with pleural effusions. It demonstrated that NT-proBNP better identified patients with heart failure-related effusions than BNP, including those transudates misclassified by Light's criteria.
14. Han CH, Choi JE, Chung JH. Clinical utility of pleural fluid NT-pro brain natriuretic peptide (NT-proBNP) in patients with pleural effusions. Intern Med 2008; 47:1669-1674.
15. Zhou Q, Ye ZJ, Su Y, et al. Diagnostic value of N-terminal pro-brain natriuretic peptide for pleural effusion due to heart failure: a meta-analysis. Heart 2010; 96:1207-1211.
16. Janda S, Swiston J. Diagnostic accuracy of pleural fluid NT-pro-BNP for pleural effusions of cardiac origin: a systematic review and meta-analysis. BMC Pulm Med 2010; 10:58. This meta-analysis, which included 10 publications, demonstrated that NT-proBNP levels in the pleural fluid accurately differentiated cardiac from noncardiac effusions (a pooled positive likelihood ratio of 15.2 and a negative likelihood ratio of 0.06).
17. Porcel JM, Esquerda A, Bielsa S. Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients. Eur J Intern Med 2010; 21:419-423.
18. Tomcsányi J, Nagy E, Somlói M, et al. NT-brain natriuretic peptide levels in pleural fluid distinguish between pleural transudates and exudates. Eur J Heart Fail 2004; 6:753-756. (Pubitemid 39470230)
19. Kolditz M, Halank M, Schiemanck CS, et al. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions. Eur Respir J 2006; 28:144-150. (Pubitemid 44914272)
20. Seyhan EC, Altin S, Cetinkaya E, et al. The importance of pleural fluid and serum NT-proBNP levels in differentiating pleural effusion due to heart failure from other causes of effusion. Intern Med 2009; 48:287-293.
21. Bayram M, Ozkan G, Oztekin E, et al. Role of serum and pleural fluid NT-proBNP levels in identifying pleural effusion due to heart failure. Multidisciplin Respir Med 2009; 4:175-181.
22. Hopper C, Gary Lee YC, Maskell N. Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010. Thorax 2010; 65:ii4-ii17.
23. Gegenhuber A, Mueller T, Dieplinger B, et al. Plasma B-type natriuretic peptide in patients with pleural effusions: preliminary observations. Chest 2005; 128:1003-1009. (Pubitemid 41140539)
24. Long AC, O'Neal HR, Peng S, et al. Comparison of pleural fluid N-terminal pro-brain natriuretic peptide and brain natriuretic-32 peptide levels. Chest 2010; 137:1369-1374.
25. Marinho FCA, Vargas FS, Fabri J, et al. Clinical usefulness of B-type natriuretic peptide in the diagnosis of pleural effusions due to heart failure. Respirology (in press).
26. Lindenfeld J, Albert NM, Boehmer JP, et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail 2010; 16:e1-e194.
27. Light RW. Use of pleural fluid N-terminal-pro-brain natriuretic peptide and brain natriuretic peptide in diagnosing pleural effusion due to congestive heart failure. Chest 2009; 136:656-658.